Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718494 · ClinicalTrials.gov registry record
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 299
- Enrollment target
NCT03718494: Completed study, sponsored by Mayo Clinic.
NCT03718494 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 299 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03718494 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 299 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how blood flow to the brain affects cognition in women who are postmenopausal, and how the use of hormone therapy early in menopause might change brain function. The testing in this study will add to the knowledge about brain aging in women. Researchers will determine if blood flow to the brain, brain structure, and cognition differences among women who took hormones in the past as part of Kronos Early Estrogen Prevention Study (KEEPS; NCT00154180), are currently taking hormones, or never took menopausal hormones.
Interventions
- DIAGNOSTIC_TEST Brain Magnetic Resonance Imaging (MRI)
- OTHER Neuropsychological Testing
- DIAGNOSTIC_TEST F-18 Florbetapir Positron Emission Tomography (PET) Imaging
- DIAGNOSTIC_TEST F-18 AV-1451 Positron Emission Tomography (PET) Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2019-05-22 |
| Est. Completion | 2022-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03718494
The ClinicalTrials.gov registry entry for NCT03718494 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Brain Magnetic Resonance Imaging (MRI) is the first listed.
NCT03718494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03718494 about?
NCT03718494 is a clinical study titled "Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)". The purpose of this study is to investigate how blood flow to the brain affects cognition in women who are postmenopausal, and how the use of hormone therapy early in menopause might change brain function. The testing in this study will add to the knowledge about brain aging in women. Researchers wi...
What is the current status of trial NCT03718494?
This trial is currently completed. The enrollment target is 299 participants. The study started on 2019-05-22. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT03718494?
The interventions under investigation include: Brain Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Neuropsychological Testing (OTHER), F-18 Florbetapir Positron Emission Tomography (PET) Imaging (DIAGNOSTIC_TEST), F-18 AV-1451 Positron Emission Tomography (PET) Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03718494?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.